|
IPHAF
|
Autopilot remain on, but they have been filling in with bigger amounts as...
|
|
IPHAF
|
Can't think of a better way to spend Dr. Robert Foster's new found...
|
|
IPHAF
|
According to www.sedi.ca Roche is listed as 7,385,908....
Insider name: Roche...
|
|
V.CYM
|
April 1, 2009 - Army Research Labs is experimenting with Polymer Matrix...
|
|
IPHAF
|
Roche Cellcept is under FDA risk review for various issues including PML (one...
|
|
IPHAF
|
Paladin Labs (C$16.00, C$1.02, 6.8%) said its first-quarter earnings doubled...
|
|
IPHAF
|
Could someone provide the House Positions for today?
|
|
IPHAF
|
Paladin will file NDA for Psoriasis by end of 2009 according to their news...
|
|
IPHAF
|
Just a matter of time....based on prior information.....
UPDATE 1-FDA...
|
|
IPHAF
|
Strategic Partnership announced with Paladin...see news releases
|
|
IPHAF
|
I found it interesting to note before Lux started Phase 3 back in Feb 21...
|
|
V.CYM
|
Tartam was on target for one of the announcements, although I believe some on...
|
|
IPHAF
|
IMO, this could be a possible long-term scenario explaining drawn-out low...
|
|
V.CYM
|
Hopefully, we will soon see some Cymat Analyst ratings/recommendations &...
|
|
IPHAF
|
Appears this was worth $1,128,000, 4,528,890 shares remain1383655 2009-02-20...
|
|
IPHAF
|
Check out Wyeth (acquired by Pfizer)/Amgen 1Q 2009 results for Enbrel Sales...
|
|
IPHAF
|
"While we would have liked to have seen 'non-inferiority', we...
|
|
IPHAF
|
From the Isotechnika website FAQ, last updated Mar 30, 2009....What other...
|
|
V.CYM
|
The April 2009 edition of the Foundry Mgmt & Technology features "...
|
|
IPHAF
|
An interesting article on Why Big Pharma Mergers Magnify Failures. This...
|